ABIONYX PHARMA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.11 EUR | -1.77% |
|
-4.80% | -38.40% |
| 06-14 | Abionyx: positive response from FDA, share price rises | CF |
| 06-13 | ABIONYX Pharma Completes Pre-IND Meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis | CI |
66c038534b913350cce27c224.WB3wL4SVamVH454KpuAdTkKJs-ZYwkVBRfiAHxtRaVE.DHShfM3ZCRIYjvdFkZNefwjr8oQPpCo4DrnrZkweIzM7cqlLza0rKHCQpg~532cba4be2ecc441c2fb6b35e8740a35
